CurrentRheuma
Get Weekly

Topic · page 29 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 1,121–1,160 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Arthritis Care Res (Hoboken)

    Ultraprocessed Food Intake and Risk of Systemic Lupus Erythematosus Among Women Observed in the Nurses’ Health Study Cohorts

    Cohort study

  2. Lupus Sci Med

    Impact of disease activity patterns on health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE)

    Cohort study

  3. Lupus Sci Med

    Changes in the incidence and prevalence of systemic lupus erythematosus between 1990 and 2020: an observational study using the Clinical Practice Research Datalink (CPRD)

    Cohort study

  4. Lupus

    Predictive value of Doppler echocardiography parameters for cardiovascular events in patients with systemic lupus erythematosus

    Case-control study

  5. Lupus Sci Med

    Assessment of the role of high-density lipoproteins and their immunomodulatory activity in systemic lupus erythematosus immunopathology

    Cross-sectional study

  6. Semin Arthritis Rheum

    OMERACT systemic lupus erythematosus domain survey

    Cross-sectional study

  7. Lupus

    A qualitative investigation of the experiences of patients living with antiphospholipid antibodies

    Research article

  8. Rheumatology (Oxford)

    Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study

    Cohort study

  9. Lupus Sci Med

    Towards an understanding of the biopsychosocial determinants of CVD in SLE: a scoping review

    Research article

  10. Lupus Sci Med

    When is the right time to change therapy? An observational study of the time to response to immunosuppressive drugs in systemic lupus erythematosus

    Cohort study

  11. Lupus

    Cardiac involvement in systemic lupus erythematosus: Interest of 2D global longitudinal strain

    Cohort study

  12. Rheumatology (Oxford)

    Unveiling the dynamics of B lymphocytes in systemic lupus erythematosus patients treated with belimumab through longitudinal single-cell RNA sequencing

    Mechanistic study

  13. Lupus

    A novel long noncoding RNA ENST00000597482 serves as a potential biomarker for disease activity and diagnosis of systemic lupus erythematosus

    Mechanistic study

  14. Rheumatology (Oxford)

    Immunosuppressives discontinuation after renal response in lupus nephritis: predictors of flares, time to withdrawal and long-term outcomes

    Cohort study

  15. Lupus

    Characteristics and prognosis of elderly-onset antiphospholipid syndrome: An observational cohort study

    Cohort study

  16. Lupus

    Psychological impact of life events in systemic lupus erythematosus patients – Differences between flares and remission

    Cross-sectional study

  17. Lupus

    Type I interferon gene expression signature as a marker to predict response to cyclophosphamide based treatment in proliferative lupus nephritis

    Cohort study

  18. Arthritis Rheumatol

    A Multiomic Analysis to Identify Drivers of Subclinical Vascular Disease in Systemic Lupus Erythematosus

    Cross-sectional study

  19. Ann Rheum Dis

    Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study

    Cohort study

  20. Ann Rheum Dis

    Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials

    Mechanistic study

  21. Lupus Sci Med

    Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trial

    Randomized controlled trial

  22. Lupus Sci Med

    Outcome clusters and their stability over 1 year in patients with SLE: self-reported and performance-based cognitive function, disease activity, mood and health-related quality of life

    Cohort study

  23. Lupus Sci Med

    Real-world effectiveness of belimumab in patients with lupus in China: RELIABLE observational cohort study protocol

    Trial design

  24. Arthritis Rheumatol

    Air Pollution, Genetic Susceptibility, and Risk of Incident Systemic Lupus Erythematosus: A Prospective Cohort Study

    Cohort study

  25. Lupus Sci Med

    Antiplatelet effects of hydroxychloroquine in patients with systemic lupus erythematosus evaluated by the total thrombus-formation analysis system (T-TAS)

    Cross-sectional study

  26. Joint Bone Spine

    Cluster analysis of clinical manifestations assigns systemic lupus erythematosus-phenotype subgroups: A multicentre study on 440 patients

    Cohort study

  27. Arthritis Res Ther

    Investigation of ferroptosis-associated molecular subtypes and immunological characteristics in lupus nephritis based on artificial neural network learning

    Mechanistic study

  28. Semin Arthritis Rheum

    Modelling long-term outcomes for patients with systemic lupus erythematosus

    Cohort study

  29. Joint Bone Spine

    Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawal

    Case-control study

  30. Arthritis Care Res (Hoboken)

    Hydroxychloroquine Improves Low Complement Levels

    Cohort study

  31. J Rheumatol

    Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus

    Cohort study

  32. J Rheumatol

    Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study

    Cohort study

  33. Lupus Sci Med

    Intercurrent infection as a risk factor for disease flares in patients with systemic lupus erythematosus

    Cohort study

  34. RMD Open

    Anti-dsDNA IgE: a potential non-invasive test for prediction of lupus nephritis relapse

    Randomized controlled trial

  35. Arthritis Rheumatol

    Impact of Glucocorticoid Dose on Complete Response, Serious Infections, and Mortality During the Initial Therapy of Lupus Nephritis: A Systematic Review and Meta‐Analysis of the Control Arms of Randomized Controlled Trials

    Meta-analysis

  36. Lupus

    Critical peripheral ischemia: Higher prevalence in Indian systemic lupus erythematosus inception cohort for research (INSPIRE)

    Cohort study

  37. Clin Exp Rheumatol

    The expression of Siglec-10 on naive B cells is involved in the pathology of systemic lupus erythematosus

    Mechanistic study

  38. Arthritis Care Res (Hoboken)

    Multiplicative Impact of Adverse Social Determinants of Health on Outcomes in Lupus Nephritis: A Meta‐analysis and Systematic Review

    Meta-analysis

  39. Arthritis Rheumatol

    Hydroxychloroquine Dose and Hospitalizations for Active Lupus

    Research article

  40. Lupus

    Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark

    Research article

All 1,848 Briefs in ExploreShowing Briefs 1,121–1,160 of 1,848, newest first